Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Caputi

Showing results (221-230 of 280) with videos related to

Pageof 28
Sort By:
European Journal of Neurology|October 2, 2007
Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005R Savica, E Beghi, G Mazzaglia, et al.
Arthritis and Rheumatism|February 29, 2000
Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritisS Cuzzocrea, M C McDonald, H Mota-Filipe, et al.
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|January 1, 1976
Experimental analysis of the specific and aspecific activity of tolamolol (dl-UK 6558)E Marmo, E Lampa, A P Caputi, et al.
Neuropharmacology|January 1, 1994
Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in ratsF Squadrito, G Calapai, D Altavilla, et al.
Agents and Actions|July 1, 1993
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injuryF Squadrito, M Ioculano, D Altavilla, et al.
Pharmacology|September 1, 1993
G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in ratsF Squadrito, M Ioculano, D Altavilla, et al.
Agents and Actions|October 1, 1994
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shockP Canale, F Squadrito, D Altavilla, et al.
European Journal of Pharmacology|January 5, 1993
Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker ratsF Squadrito, G Calapai, D Cucinotta, et al.
European Journal of Pharmacology|April 16, 1999
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shockD Altavilla, F Squadrito, G M Campo, et al.
The American Journal of Pathology|December 7, 2000
Calpain inhibitor I reduces the development of acute and chronic inflammationS Cuzzocrea, M C McDonald, E Mazzon, et al.
Pageof 28

Showing results (221-230 of 280) with videos related to

Sort By:
Pageof 28
European Journal of Neurology|October 2, 2007
Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005R Savica, E Beghi, G Mazzaglia, et al.
Arthritis and Rheumatism|February 29, 2000
Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritisS Cuzzocrea, M C McDonald, H Mota-Filipe, et al.
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|January 1, 1976
Experimental analysis of the specific and aspecific activity of tolamolol (dl-UK 6558)E Marmo, E Lampa, A P Caputi, et al.
Neuropharmacology|January 1, 1994
Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in ratsF Squadrito, G Calapai, D Altavilla, et al.
Agents and Actions|July 1, 1993
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injuryF Squadrito, M Ioculano, D Altavilla, et al.
Pharmacology|September 1, 1993
G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in ratsF Squadrito, M Ioculano, D Altavilla, et al.
Agents and Actions|October 1, 1994
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shockP Canale, F Squadrito, D Altavilla, et al.
European Journal of Pharmacology|January 5, 1993
Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker ratsF Squadrito, G Calapai, D Cucinotta, et al.
European Journal of Pharmacology|April 16, 1999
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shockD Altavilla, F Squadrito, G M Campo, et al.
The American Journal of Pathology|December 7, 2000
Calpain inhibitor I reduces the development of acute and chronic inflammationS Cuzzocrea, M C McDonald, E Mazzon, et al.
Pageof 28